Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tamer M Fouad

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Cancer|October 19, 2017
BRCA mutations in women with inflammatory breast cancerAngelica M Gutierrez Barrera, Tamer M Fouad, Juhee Song, et al.
Journal of Cancer|August 19, 2017
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free SurvivalShane R Stecklein, Jay P Reddy, Adam R Wolfe, et al.
Therapeutic Advances in Medical Oncology|July 19, 2017
Novel therapeutic strategies in the treatment of triple-negative breast cancerKarima Oualla, Heba M El-Zawahry, Banu Arun, et al.
The Oncologist|December 15, 2015
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Diane D Liu, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 6, 2012
Clinical features and treatment outcome of acute promyelocytic leukemia patients treated at cairo national cancer institute in egyptOla Khorshid, Amira Diaa, Mohamed Abd El Moaty, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
The Lancet. Oncology|April 4, 2017
Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging systemTamer M Fouad, Angelica M Gutierrez Barrera, James M Reuben, et al.
The Oncologist|February 1, 2020
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without TrastuzumabTakahiro Kogawa, Takeo Fujii, Jimin Wu, et al.
Journal of Cancer|March 14, 2015
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Caimiao Wei, et al.
Breast Cancer Research : BCR|January 10, 2015
Circulating tumor cells in newly diagnosed inflammatory breast cancerMichal Mego, Antonio Giordano, Ugo De Giorgi, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Cancer|October 19, 2017
BRCA mutations in women with inflammatory breast cancerAngelica M Gutierrez Barrera, Tamer M Fouad, Juhee Song, et al.
Journal of Cancer|August 19, 2017
Lack of Breastfeeding History in Parous Women with Inflammatory Breast Cancer Predicts Poor Disease-Free SurvivalShane R Stecklein, Jay P Reddy, Adam R Wolfe, et al.
Therapeutic Advances in Medical Oncology|July 19, 2017
Novel therapeutic strategies in the treatment of triple-negative breast cancerKarima Oualla, Heba M El-Zawahry, Banu Arun, et al.
The Oncologist|December 15, 2015
High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Diane D Liu, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 6, 2012
Clinical features and treatment outcome of acute promyelocytic leukemia patients treated at cairo national cancer institute in egyptOla Khorshid, Amira Diaa, Mohamed Abd El Moaty, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
The Lancet. Oncology|April 4, 2017
Inflammatory breast cancer: a proposed conceptual shift in the UICC-AJCC TNM staging systemTamer M Fouad, Angelica M Gutierrez Barrera, James M Reuben, et al.
The Oncologist|February 1, 2020
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without TrastuzumabTakahiro Kogawa, Takeo Fujii, Jimin Wu, et al.
Journal of Cancer|March 14, 2015
Association of Body Mass Index Changes during Neoadjuvant Chemotherapy with Pathologic Complete Response and Clinical Outcomes in Patients with Locally Advanced Breast CancerTakahiro Kogawa, Tamer M Fouad, Caimiao Wei, et al.
Breast Cancer Research : BCR|January 10, 2015
Circulating tumor cells in newly diagnosed inflammatory breast cancerMichal Mego, Antonio Giordano, Ugo De Giorgi, et al.
Pageof 3